Why is "Hospira" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-06-23 11:53:05
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Hospira entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-06-23 and was most recently seen on 2026-06-23.
Wikipedia Overview
Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois. It had approximately 19,000 employees. Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. Hospira's products are used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. It was formerly the hospital products division of Abbott Laboratories. On September 3, 2015, Hospira was acquired by Pfizer, who subsequently sold off the medical devices portion of Hospira to ICU Medical.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Hospira Recalls Another Lot of Propofol - Managed Healthcare Executive
-
Federal Circuit affirms Safe Harbor ruling and $70 million award in Amgen Inc. v. Hospira, Inc. - Mintz
-
Hospira, Inc. Issues A Voluntary Nationwide Recall For 4.2% Sodium Bicarbonate Injection, USP and 1% and 2% Lidocaine HCl Injection, USP Due To The Potential For Presence of Glass Particulate Matter - pfizer.com
-
Citing hacking risk, FDA says Hospira pump shouldn't be used - CNBC
-
UPDATED: Pfizer closing Hospira plant in Colorado, 100 jobs to be lost - Fierce Pharma
-
Lethal injection drug production ends in the US - The Guardian
-
Pfizer to shed four Hospira sites - BioPharma Dive
-
Once again, Pfizer halts production at a Hospira plant over manufacturing gaffes - STAT
-
Pfizer to Buy Hospira for $16 Billion - WSJ
-
Pfizer to buy Hospira for $15 billion to bolster hospital products - Reuters
-
Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling - pfizer.com
-
Hospira gives Pfizer big Q2 revenue boost as new brands Ibrance, Xeljanz offset Prevnar fall - Fierce Pharma
-
Pfizer making progress on Hospira manufacturing issues, execs say - BioPharma Dive
-
Hospira to Stop Making Lethal-Injection Drug - WSJ
-
Pfizer's Hospira recall spree bleeds into 2024 with product pulls for multiple hospital drugs in shortage - Fierce Pharma
-
Hospira Issues A Voluntary Nationwide Recall For Labetalol Hydrochloride Injection, USP, Due To The Potential Of Cracked Glass At The Rim Surface Of The Vials - pfizer.com
-
Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), Due To The Potential Presence of Visible Particulate. - pfizer.com
-
Pfizer's Hospira recalls 5 injectable drug lots due to report of leak, potential seal issues - Fierce Pharma
-
Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Bleomycin for Injection, USP 15 Units Single Dose ONCO-TAIN™ Glass Fliptop Vial Due To The Potential For Presence of Glass Particulate Matter - pfizer.com
-
Pfizer to shutter 4 Hospira distribution centers, laying off 104 - Fierce Pharma
-
Problems at Hospira plants dog Pfizer and some of its clients - Fierce Pharma
-
Pfizer still unable to get on top of problems at Hospira injectables plant - Fierce Pharma
-
Hospira closes North Carolina plant over cost concerns - BioPharma Dive
-
CDMO Avara snaps up former Hospira sterile plant from Pfizer - Fierce Pharma
-
FDA warns against pediatric use of Hospira’s potassium phosphates drug product - Contemporary Pediatrics
-
Pfizer's Hospira recalls hospital anesthetics, flags 'moderate to high severity' safety risks - Fierce Pharma
-
Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (containing benzyl alcohol), Due To The Potential Presence of Visible Particulates - pfizer.com
-
Pfizer to sell Hospira Infusion Systems to ICU Medical - Chemistry World
-
Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate - pfizer.com
-
After Cutting Hundreds of Hospira-Related Jobs, Pfizer Sells Hospira Infusion Systems Biz in in $1 Billion Deal - BioSpace
-
U.K. finds big issues with Pfizer Hospira plant in India - Fierce Pharma
-
Pfizer offloads Hospira infusion therapy unit to ICU Medical for $1B - Fierce Biotech
-
Pfizer puts 1,700 jobs in jeopardy with 2 Hospira plant shutdowns in India - Fierce Pharma
-
Hospira experience will aid Abzena success, says new CEO - BioProcess International
-
Particulates, label issues prompt separate recalls for Pfizer's Hospira and Accord - Fierce Pharma
-
The FDA warns Pfizer over yet another former Hospira manufacturing plant - STAT
-
Quality Control Issues: Hospira, Inc. - Motley Rice
-
Pfizer Buying Lake Forest-Based Hospira For $15 Billion - cbsnews.com
-
Pfizer suspends work at Hospira India plant as FDA turns up heat - Fierce Pharma
-
Pfizer makes moves to offload Hospira's pumps and devices business - Fierce Pharma
-
ICU Medical closes $900m buyout of Pfizer’s Hospira infusion pump biz - MassDevice
-
Hospira marks five years of biosimilars - Generics and Biosimilars Initiative
-
EXCLUSIVE: Pfizer explores sale of hospital drugs unit, sources say - Reuters
-
Hospira issues voluntary recall of hydromorphone due to possible cracked vials - Fierce Pharma
-
FDA Warns on Use of Hospira Drug in Kids Due to 'Unsafe' Aluminum Levels - MedPage Today
-
Pfizer may still be hungry after Hospira deal - BioPharma Dive
-
US pharmaceutical firm Hospira under fire over use of its drugs in executions - The Guardian
-
Pfizer's Hospira escapes adrenaline patent claims based on PTO omissions - Reuters
-
Mylan and Hospira both recall injected drugs after particulate discovered in vials - Fierce Pharma
-
Hospira's recall, Teva's shuttering of troubled plant tighten supply pinch on propofol - Fierce Pharma
-
Federal Circuit Cautions Against Rigid Approach to Prosecution History Estoppel in Fourth Appeal from ALIMTA® Litigations - Mintz
-
Hospira Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™ - PR Newswire
-
Pfizer looks to right sterile injectable woes with modernized manufacturing - Fierce Pharma
-
Hospira announces launch of first biosimilar monoclonal antibody in Europe - News-Medical
-
Hospira recalls injectable diabetes medicine due to presence of glass particles - FOX 5 Atlanta
-
Novartis hires Hospira's $90 million man to save Alcon - Reuters
-
Former Hospira chief’s platinum parachute: $91 million in cash - BioPharma Dive
-
Pfizer's Hospira recalls 3 drug lots over particulate concerns - Fierce Pharma
-
Hospira recall of ketorolac now close to 40 million vials - Fierce Pharma
-
Hospira Unveils New Quality Laboratory and Investments at Rocky Mount, N.C., Plant - PR Newswire
-
Pfizer unloads Colorado plant as it continues to hive off unwanted Hospira operations - Fierce Pharma
-
Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role - PR Newswire
-
Pfizer’s Hospira issues recall for lots of hydromorphone and Levophed - Fierce Pharma
-
Hospira Recalls Buprenorphine, Labetalol Injectables Due to Packaging Defect - Medical Professionals Reference
-
Workers Pfizer will whack at Hospira plants in India to get ‘attractive’ severance - Fierce Pharma
-
What does Pfizer get with the Hospira deal? - CNBC
-
Hospira Launches Q Core Sapphire Infusion System in the United States - PR Newswire
-
Pfizer’s Hospital-Drug Problems Won’t Go Away - bloomberg.com
-
Hospira Names David J. Endicott President of Medical Devices - PR Newswire
-
Fat Pharma: Pfizer-Hospira and the top 10 overpriced drug deals ever - Fortune
-
Hospira recalls injected dextrose for infants, one of its products in short supply - Fierce Pharma
-
Concerns at Wockhardt, Hospira plants factor into CRL issued to Cempra - Fierce Pharma
-
Hospira Receives U.S. FDA Approval of Proprietary Analgesic Dyloject™(diclofenac sodium) Injection - PR Newswire
-
Pfizer buying Hospira for about $15.23 billion - chicago.suntimes.com
-
The Pfizer-Hospira Deal: Do Pharma and Device Companies Need Each Other? - MassDevice
-
Hospira stock soars as Pfizer says it will buy for $15.23 billion - Chicago Tribune
-
Pfizer Gets U.S. Approval to Acquire Hospira - WSJ
-
Hospira Completes Acquisition of Orchid's Active Pharmaceutical Ingredient Manufacturing and R&D Facility - PR Newswire
-
Pfizer’s Hospira Acquisition Good for Its Stock But What About Its Bonds? - blogs.barrons.com
-
Hospira re-launches oxaliplatin injection in U.S. - Healthcare Digital
-
Pfizer Completes Acquisition of Hospira - PharmTech.com
-
Hospira recall of vials adds to woes of sodium bicarbonate shortage - Fierce Pharma
-
Amid Biden admin's drug-pricing push, Big Pharma kicks off 2024 with hundreds of price hikes: report - Fierce Pharma
-
FDA Approves New Indication for Hospira, Inc.'s Precedex (Dexmedetomidine HCL) Injection - Fierce Biotech
-
Pfizer's Hospira Plant Receives FDA Form 483 - Center for Biosimilars
-
Hospira recalls injectable diabetes medicine due to presence of glass particles - fox7austin.com
-
Hospira Announces Propofol Recall Due to Possible Particulate in Vial - Medical Professionals Reference
-
Pfizer to Shut Down Four Hospira Distribution Centers - BioSpace
-
Pfizer closes $15B Hospira takeover - MassDevice
-
Hospira closing US manufacturing plant - Pharmafile
-
FDA Approves New Indication for Hospira's Precedex (Dexmedetomidine HCL) Injection - Fierce Biotech
-
Pfizer closes plant in India after several regulators find problems - STAT
-
Hospira again shipping ketorolac but U.S. faces many drug shortages - Fierce Pharma
-
Hospira recalls Naloxone injections due to potential of 'particulate matter' - Local 3 News
-
Pfizer's massive North Carolina plant heavily damaged by tornado, prompting new US drug supply fears - Fierce Pharma
-
Drug maker Hospira recalls naloxone - WSAZ
-
Hospira Profit Tops Expectations on Injectables Strength - WSJ
-
Painkiller in Short Supply Following Hospira Recall - WSJ
-
Hospira Carpuject Recall Issued Due to Potential Leaks of Some Drug Products - AboutLawsuits.com
-
Hospira hit with further FDA scrutiny after $17 billion Pfizer deal - Fortune
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.